Any drug interaction between ovaa shield ds and pan 40, buscopan

Reading File
Finding Sources
Searching the Web

Ovaa Shield DS diosmin hesperidin pantoprazole hyoscine buscopan drug interaction

Searching the Web

hyoscine butylbromide buscopan pantoprazole diosmin drug interaction

Finding Sources
Here is a full breakdown of the drug interactions between these three medications:

Drug Interaction Analysis: Ovaa Shield DS + Pan 40 + Buscopan

The Three Drugs at a Glance

DrugGenericClass
Ovaa Shield DSDiosmin 900 mg + Hesperidin 100 mgVenotonic / Flavonoid
Pan 40Pantoprazole 40 mgProton Pump Inhibitor (PPI)
BuscopanHyoscine butylbromide 10 mgAnticholinergic antispasmodic

Interaction 1: Ovaa Shield DS + Pan 40

No clinically significant interaction known.
  • Diosmin/hesperidin are flavonoids that primarily act on venous tone and capillary permeability. They are not known to meaningfully alter the CYP2C19 metabolism of pantoprazole.
  • Pantoprazole does not affect diosmin absorption or efficacy.
  • The combination is safe and sometimes prescribed together in pelvic/abdominal conditions.

Interaction 2: Ovaa Shield DS + Buscopan

No clinically significant interaction known.
  • Diosmin and hesperidin have no anticholinergic activity and do not potentiate or antagonize Buscopan's smooth muscle relaxing effect.
  • Safe to co-administer.

Interaction 3: Pan 40 + Buscopan

Minor / theoretical interaction - generally safe.
  • Buscopan (hyoscine) has anticholinergic properties that slow GI motility. This can theoretically delay gastric emptying and slightly prolong pantoprazole's transit time, but this is not clinically significant at standard doses.
  • Buscopan's known significant drug interactions are with other anticholinergics (additive effects), amantadine, beta-adrenergic agents, antihistamines, and tricyclic antidepressants - NOT with PPIs.
  • In fact, pantoprazole + hyoscine butylbromide is a studied combination used together in emergency departments for dyspeptic/abdominal pain (NCT01281501).

Key Safety Notes

  1. Bleeding risk with diosmin (Ovaa Shield DS): Health Canada has flagged that diosmin/hesperidin may increase bleeding risk and may raise levels of anticoagulants (e.g., warfarin) in the blood. If the patient is also on any blood thinner, this combination requires caution. Pan 40 + Buscopan are not blood thinners, so this is not a concern here.
  2. Buscopan contraindications to check regardless of co-administration: Glaucoma, myasthenia gravis, prostatic enlargement, pyloric stenosis - these are contraindications to Buscopan itself, not interaction-related.
  3. Pantoprazole's notable interactions (not relevant to this trio): Warfarin, HIV antiretrovirals (rilpivirine, atazanavir), iron supplements, methotrexate. None of these are in this drug combination.

Bottom Line

No clinically significant drug interactions exist between Ovaa Shield DS, Pan 40, and Buscopan. This is a commonly co-prescribed combination in gastroenterology and gynecology (e.g., pelvic varicosities, IBS, dyspepsia with spasm). The combination is generally well tolerated.
As always, advise patients to report unusual bruising or bleeding while on diosmin-containing products, especially if they are also on anticoagulants or NSAIDs.

Ovaa shield ds uses

Finding Sources
Searching the Web

Ovaa Shield DS diosmin hesperidin uses indications gynecology

Searching the Web

Ovaa Shield DS tablet uses pelvic congestion endometriosis India prescribing

Reading Web Page

https://shieldhealthcare.in/clinical-resources

Here is a complete overview of Ovaa Shield DS and its uses:

Ovaa Shield DS - Uses & Clinical Profile

Composition

Diosmin 900 mg + Hesperidin 100 mg (double-strength / DS formulation)
This is the higher-potency version of Ovaa Shield, manufactured by Shield Healthcare (India). The standard version contains Diosmin 450 mg + Hesperidin 50 mg.

Primary Uses

1. Ovulation Induction / Female Infertility (Key Indian Indication)

  • Prescribed in India to women requiring enhanced ovulation support, particularly when standard ovulation induction is insufficient.
  • Helps improve chances of natural conception by promoting an effective ovulatory response.
  • Supports implantation and early pregnancy maintenance through optimized reproductive function.
  • Used under medical supervision as a stronger stimulant for egg release.
  • Indicated for women who need stronger ovulation induction (hence the DS = Double Strength).

2. Chronic Venous Insufficiency (CVI)

  • Reduces symptoms of venous disease: leg heaviness, pain, fatigue, swelling, and cramps.
  • Improves venous tone and reduces venous hypertension.
  • Used in varicose veins and post-thrombotic syndrome.

3. Hemorrhoidal Disease

  • Used in both acute and chronic hemorrhoids.
  • Reduces bleeding, pain, swelling, and discomfort associated with hemorrhoids.
  • One of the most well-studied uses of diosmin/hesperidin globally.

4. Pelvic Congestion Syndrome

  • Used in women (and men) with pelvic varicose veins causing chronic pelvic pain.
  • Clinical studies show improvement in pelvic pain scores after 6 months of use in multiparous women with pelvic congestion syndrome.

5. Lymphedema (Adjunct)

  • Used as an adjunct in lymphatic drainage insufficiency and lymphedema management.
  • Reduces capillary permeability and improves lymphatic drainage.

6. Venous Leg Ulcers

  • Supports healing of chronic venous ulcers when used alongside compression therapy.

7. Capillary Fragility

  • Reduces bruising and bleeding tendency from fragile capillaries (micro-angiopathy protection).

Mechanism of Action

Diosmin + Hesperidin (as Micronized Purified Flavonoid Fraction - MPFF) works by:
  • Increasing venous tone - reduces venous distension and stasis
  • Reducing capillary permeability - decreases fluid leakage into tissues
  • Anti-inflammatory - inhibits prostaglandins, thromboxane, and free radicals
  • Improving lymphatic drainage - increases lymphatic contractility
  • Antioxidant - protects endothelial cells from oxidative damage

Dosing (Typical)

IndicationDose
Ovulation support / infertilityAs directed by gynecologist
Acute hemorrhoids2 tablets/day (DS) for 4 days, then 1 tablet/day
Chronic venous insufficiency1 tablet/day (DS)
Pelvic congestion1 tablet/day for up to 6 months

Important Notes

  • Pregnancy: Safety data is limited; use only when prescribed by a doctor.
  • Bleeding risk: May increase bleeding risk; caution with anticoagulants (warfarin, heparin).
  • Not a hormonal drug - works as a venotonic and antioxidant, not as a hormone.
  • Requires a prescription in India for the DS (double-strength) formulation.
This is a shared conversation. Sign in to Orris to start your own chat.